# EntroGen

Source: https://onco.cc/companies/entrogen/  
OnCo record `entrogen` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Californian maker of PCR test kits whose CRCdx RAS test is an FDA companion diagnostic for panitumumab.

## Summary

EntroGen makes real-time PCR reagents, automation and software for molecular laboratories. Its CRCdx RAS Mutation Detection Assay Kit was approved by the FDA in September 2023 as the companion diagnostic for panitumumab in KRAS and NRAS wild-type colorectal cancer.

## Fields

- Kind: Company
- Last checked: 2026-11-03
- HQ: Woodland Hills, CA
- Type: diagnostics
- Website: https://www.entrogen.com

## Sources

- Official website: https://www.entrogen.com
- FDA PMA P220005: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P220005

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Companion diagnostics](https://onco.cc/technologies/companion-diagnostic/)
- drugs: [CRCDx RAS Mutation Detection Assay Kit](https://onco.cc/drugs/crcdx-ras/)

---
JSON: https://onco.cc/api/v1/entities/entrogen.json